Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Renaissance Pharma Inc.

Division of Renaissance Acquisition Holdings LLC
www.renaissancepharmainc.com

Latest From Renaissance Pharma Inc.

The End Is Nigh For Mylan, But How Different Will The New Company Be?

Mylan will be merged into a new company with Pfizer’s Upjohn, closing the chapter on a generic drug powerhouse that will be remembered as much for scandal as success.

Business Strategies Deals

Appointments: Astellas, BIO, Hikma, Eton, Akili and Oxford BioDynamics

This week's roundup includes CEO appointments by Eton Pharmaceuticals, the Biotechnology Innovation Organization and Hikma, in addition to various other high-level appointments by Astellas, Akili Interactive Labs and Oxford BioDynamics.

BioPharmaceutical Appointments

Generic Manufacturers Try To Up Their Game As US Pressure Persists

With US generic drug price erosion running at double digits, 2017 is expected to be a challenging year for the generic drug sector. Manufacturers are looking increasingly to complex generics, injectables and biosimilars as an offset, but it's unclear if wins in those areas will be enough to bridge the growth divide.

Generic Drugs Business Strategies

Generic Manufacturers Try To Up Their Game As US Pressure Persists

With US generic drug price erosion running at double digits, 2017 is expected to be a challenging year for the generic drug sector. Manufacturers are looking increasingly to complex generics, injectables and biosimilars as an offset, but it's unclear if wins in those areas will be enough to bridge the growth divide.

Generic Drugs Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Renaissance Acquisition Holdings LLC
  • Senior Management
  • Patrick D McIntosh, VP, Commerical Operations
    Louis J Pearce, Dir., Fin.
    John W Denman, General Manager
    Greg Besase, VP, Branded Products
    Soby M Fennell, Dir, Reg Affairs
    Rafal Czapla, Marketing Manager
  • Contact Info
  • Renaissance Pharma Inc.
    Phone: (267) 685-0340
    411 S. State St.
    Ste. E-100
    Newtown, PA 18940
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register